Literature DB >> 9280040

Comparative calibration without a gold standard.

Y Lu1, K Ye, A K Mathur, S Hui, T P Fuerst, H K Genant.   

Abstract

Comparative calibration is the broad statistical methodology used to assess the calibration of a set of p instruments, each designed to measure the same characteristic, on a common group of individuals. Different from the usual calibration problem, the true underlying quantity measured is unobservable. Many authors have shown that this problem, in general, does not have a unique solution. Most commonly used assumptions to obtain a unique solution are (i) one instrument is the gold standard (that is, unbiased) and (ii) the measurement errors of the p instruments are independent. Such constraints, however, may not be valid for many clinical applications, for example, the universal standardization project for dual X-ray absorptiometry (DXA) scanners. In this paper, we propose a new approach to resolve the comparative calibration problem when a gold standard is unavailable. Instead of the usual assumptions, we use external information in addition to data from the p instruments, to solve the problem. We address statistical estimation, hypothesis testing and missing data problems. We apply the new method specifically to the universal standardization project data where a group of individuals have been measured for bone mineral density (BMD) by three DXA scanners. We compare the results of the new method to currently used methods and show that they have better statistical properties.

Entities:  

Mesh:

Year:  1997        PMID: 9280040     DOI: 10.1002/(sici)1097-0258(19970830)16:16<1889::aid-sim607>3.0.co;2-v

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

1.  A simple method for determining the probability a new vertebral fracture is present in postmenopausal women with osteoporosis.

Authors:  J H Krege; K Siminoski; J D Adachi; D A Misurski; P Chen
Journal:  Osteoporos Int       Date:  2005-11-22       Impact factor: 4.507

2.  Comment on Tothill and Hannan: precision and accuracy of measuring changes in bone mineral density by dual-energy X-ray absorptiometry.

Authors:  G Phillipov; C J Seaborn
Journal:  Osteoporos Int       Date:  2008-01-29       Impact factor: 4.507

3.  Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.

Authors:  P D Miller; E N Schwartz; P Chen; D A Misurski; J H Krege
Journal:  Osteoporos Int       Date:  2006-09-30       Impact factor: 4.507

4.  Denosumab is really effective in the treatment of osteoporosis secondary to hypogonadism in prostate carcinoma patients? A prospective randomized multicenter international study.

Authors:  Carlo Doria; Paolo Tranquilli Leali; Federico Solla; Gianluca Maestretti; Massimo Balsano; Robero Mario Scarpa
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

5.  The effect of raloxifene treatment in postmenopausal women with CKD.

Authors:  Areef Ishani; Terri Blackwell; Sophie A Jamal; Steven R Cummings; Kristine E Ensrud
Journal:  J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 10.121

6.  Bayesian Peer Calibration with Application to Alcohol Use.

Authors:  Miles Q Ott; Joseph W Hogan; Krista J Gile; Crystal Linkletter; Nancy P Barnett
Journal:  Stat Med       Date:  2016-03-04       Impact factor: 2.373

7.  Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.

Authors:  Jean Yves Reginster; Dieter Felsenberg; Imre Pavo; Jan Stepan; Juraj Payer; Heinrich Resch; Claus C Glüer; Dieter Mühlenbacher; Deborah Quail; Henry Schmitt; Thomas Nickelsen
Journal:  Osteoporos Int       Date:  2003-06-19       Impact factor: 4.507

8.  Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial.

Authors:  H Morii; Y Ohashi; Y Taketani; M Fukunaga; T Nakamura; A Itabashi; S Sarkar; K Harper
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

9.  Enhanced prediction of fracture risk combining vertebral fracture status and BMD.

Authors:  E S Siris; H K Genant; A J Laster; P Chen; D A Misurski; J H Krege
Journal:  Osteoporos Int       Date:  2007-01-24       Impact factor: 5.071

10.  Treatment effects on measures of body composition in the TODAY clinical trial.

Authors: 
Journal:  Diabetes Care       Date:  2013-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.